CEROW
CERO THERAPEUTICS HOLDINGS, INC.
NASDAQ · Healthcare · Biotechnology · US
$0.00
−34.55%Price chart
May 27Jun 4Jun 9Jul 7Jul 31Aug 17Sep 2Sep 18
Key dataSep 18, 2026
Open$0.00
From 52W high−94.71%
Volume2000.00
Market cap$2276.79
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataSep 18, 2026
Open
$0.00
From 52W high
−94.71%
Volume
2000.00
Market cap
$2276.79
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.4x
P/E (TTM)
—
RSI (14)
51.1
MomentumView details →
1D Return
−34.55%
YTD Return
−33.93%
Similar companies
Latest newsMore news →
CERO Therapeutics Holdings, Inc. signed a consolidated senior secured promissory note with SRX Global Inc. for up to $11,666,108.77, consolidating previous notes and providing additional advances, with interest at 10% per annum and maturity on October 15, 2026.20d agoSRX Global Inc. issued 3,579 shares of Series C Convertible Preferred Stock to an accredited investor for $2,862,500, paid via assignment of Convertible Grid Promissory Notes from CERO Therapeutics Holdings, Inc., in a private placement under Regulation D Rule 506(b).23d agoCero Therapeutics Holdings, Inc. entered into a Second Amended and Restated Convertible Grid Promissory Note due 2027, providing for maximum aggregate borrowings of $2,085,200, fully funded as of the signing date, with interest at 10% per annum and conversion into common stock.66d ago